<DOC>
	<DOCNO>NCT02209532</DOCNO>
	<brief_summary>This randomize , prospective , open label , multicenter study ass safety utility PINPOINT® Near Infrared Fluorescence Imaging ( PINPOINT ) identification lymph node ( LN ) patient uterine cervical malignancy undergo LN mapping .</brief_summary>
	<brief_title>A Study Assessing Safety Utility PINPOINT® Near Infrared Fluorescence Imaging Identification Lymph Nodes Patients With Uterine Cervical Malignancies Who Are Undergoing Lymph Node Mapping</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Uterine Neoplasms</mesh_term>
	<criteria>18 year age old Subjects FIGO Clinical Stage I endometrial cancer undergo minimally invasive hysterectomy lymph node mapping . Subjects FIGO Clinical Stage IA cervical cancer ≤ 2 cm size undergo minimally invasive hysterectomy , trachelectomy , conization lymph node mapping . Subjects clinical Stage IA1 cervical cancer without lympho vascular space involvement ( LVSI ) negative margin cone biopsy include . Subjects negative nodal status ( N0 ) Subjects negative metastatic involvement ( M0 ) . Have prior dissection and/or radiation pelvis . Advanced cervical endometrial cancer , T3/T4 lesions Diagnosis cervical cancer tumor size great 2 cm . Locally advanced inflammatory cervical uterine cancer Metastatic cervical uterine cancer . Known allergy history adverse reaction ICG , iodine iodine dye . Known allergy history adverse reaction Blue dye ( Isosulfan blue ) triphenylmethane . Hepatic dysfunction define MELD Score &gt; 12 . Renal dysfunction define serum creatinine ≥ 2.0 mg/dl . Subjects participate another investigational study within 30 day prior surgery . Pregnant lactating subject . Subjects , Investigator 's opinion , medical condition make subject poor candidate investigational procedure , interfere interpretation study result .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Lymph node mapping</keyword>
	<keyword>Endometrial cancer</keyword>
	<keyword>Uterine cancer</keyword>
	<keyword>Cervical cancer</keyword>
</DOC>